Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
SELUTION SLR™ 014 In-stent Restenosis

treatment with either the SELUTION SLR™ DEB or SOC to include contemporary DES (zotarolimus-eluting stents and everolimus-eluting stents only) or non-DEB BA. A maximum of 418 randomized subjects will be

unstable angina
infarct
ticagrelor
ischemia
aspirin
  • 0 views
  • 23 Apr, 2022
  • 2 locations
Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial

Previous randomized clinical trials have deomonstrated the efficacy and safety of short-term dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), however, the single antiplatelet agent to be maintained after short-term DAPT was different. Therefore, which antiplatelet agent to be maintained after short-term DAPT needs further invstigations.

  • 0 views
  • 22 Oct, 2022
  • 1 location
Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk (ZEVS-HBR)

percutaneous intervention with a zotarolimus eluting stent versus a sirolimus eluting stent and short Dual Antiplatelet Therapy (DAPT).

percutaneous coronary intervention
angiography
bypass graft
ischemia
aspirin
  • 0 views
  • 15 Mar, 2022
Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions (CAGE-FREE III)

Coronary restenosis has been one of the main reasons affecting the prognosis of patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI). With drug-eluting stents (DES), which elutes an antiproliferative drug to the vessel wall and reduces the restenosis rate; however, the incidence of restenosis is still about …

percutaneous coronary intervention
paclitaxel
infarct
ticagrelor
ischemia
  • 0 views
  • 04 Oct, 2022
  • 1 location
Gangwon PCI Registry

stent, Abbott, USA Zotarolimus-eluting stent, Endeavor Resolute, or Endeavor Resolute Integrity stent Medtronic, USA in patients with coronary artery disease treated with

unstable angina
percutaneous coronary intervention
infarct
coronary artery stenosis
ischemia
  • 4 views
  • 05 Aug, 2021
  • 3 locations
Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT (ONYSOVER)

Investigators aimed to evaluate efficacy and safety of expansion capacity of zotarolimus-eluting durable-polymer stent assessed by optical coherence tomography (OCT) in vitro and vivo study.

percutaneous coronary intervention
zotarolimus
  • 0 views
  • 11 May, 2022
  • 1 location